Skip to content 
- [PRESSWIRE] Australia – 02.06.14 — Starting this month all the pharmacies in Australia can access ”Nasodren®: a new approach to Rhinosinusitis”, a course offered by iTherapeutics.
- [PRESSWIRE] London, UK – 03.06.14 — The Butterfly Tree has been given a licence to import two safe new products to use in the prevention of malaria and other vector-borne diseases.
- [PRESSWIRE] Australia – 09.06.14 — Sinusitis is a condition currently affecting three million Australians. Breathe through your nose again using Nasodren® for sinusitis treatment. The fast acting treatment that starts working from the first application.
- [PRESSWIRE] ISTANBUL – 11.07.14 – This year’s IFCC in Istanbul was a remarkable event for Sysmex. With one of our largest stands ever – showcasing the entire range of our products – we showed what we believe is living our mission of “Shaping the Advancement of Healthcare”. After the IFCC we can be confident we are well on our way.
- [PRESSWIRE] REDWOOD CITY, Calif. – 28.07.14 – PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that it has closed up to $50 million in secured debt financing from an investment fund managed by Pharmakon Advisors and $12 million in an extension on its Series B preferred stock.
- [PRESSWIRE] London, United Kingdom – 08.08.2014 –As part of a new collaboration, Cancer Research UK, CRT and Astellas will conduct a two-year research programme in the UK to find promising new drug targets for pancreatic cancer.
- [Presswire] New York, US, London, United Kingdom, Berlin, Germany and Paris, France – 11.08.2014 — Reportstack announces that it has published a new Wintergreen study Alcohol Breathalyzer And Drug Testing Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2014 to 2020.
- [PRESSWIRE] New York, US – 12.08.14 — A unique medical study commissioned by Andromedical (andromedical.com) shows Acute Phase Peyronie’s Disease can be successfully managed with a Traction Device in a Non-randomized Prospective Controlled Trial, with Ultrasound Correlation.
- [PRESSWIRE] Southampton, United Kingdom – 20.08.2014 — KalVista Pharmaceuticals (“KalVista”), an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME.
- [PRESSWIRE] Cambridge, Massachusetts, US, and Brisbane, Queensland, Australia – 26.08.2014 — Vaxxas, a biotechnology company commercializing a novel vaccine delivery platform, has been named a 2015 Technology Pioneer by the World Economic Forum.
- [PRESSWIRE] London, United Kingdom – 28.08.2014 — A newly published study in the Journal of Paediatrics and Child Health has revealed that a probiotic supplement could significantly improve symptoms in infants suffering from colic, without any reported side effects.
- [PRESSWIRE] NEW YORK – 05.01.14 – Onco360, one of the nation’s largest independent providers of Oncology Pharmacy services, today announced that it has been selected by Bayer AG (“Bayer”) as a limited distribution pharmacy network participant for two of its leading oncology medications, Nexavar® (sorafenib) and Stivarga® (regorafenib).
- [PRESSWIRE] EMERYVILLE, Calif. – 7 January, 2015 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company developing and commercializing non-antibiotic anti-infective products, announces a refinement of business focus on products for the eye care market featuring three primary components designed to deliver commercial and business success:
- [PRESSWIRE] Basel , April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis.
- [PRESSWIRE] Langenfeld, Germany — 11 May 2015 – The German patch and oral-film maker announces the opening of its own business development office in the US, targeting the biggest pharmaceutical market globally while improving customer focus.
- [PRESSWIRE] MADISON, N.J. – 22 September, 2015 — The refreshing flavor of mint is a pleasurable enhancement to toothpastes, chewing gums, culinary fare – and now, America’s most-preferred multivitamin brand.
- [PRESSWIRE] PINE BROOK, N.J. – 6 October, 2015 — Alvogen, today announced that it has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS.
- [PRESSWIRE] Dublin, Rep. of Ireland – 15 October 2015 — This month at “Expopharm Dusseldorf 2015”, the Dublin-based group, Civic Pharmaceuticals, has presented their newest project www.mediestoc.com, the first online business site for the pharmaceutical trade in Europe.
- [PRESSWIRE] CHICAGO – 04 February, 2016 — Brainlab AG, a global leader in cancer-fighting medical technology, showed solidarity with the World Cancer Day campaign ‘We Can. I Can.’ today by releasing a video in which employees share how they personally impact cancer. The three-year World Cancer Day campaign, outlines actions that people can take to prevent cancer, improve survival rates and reduce the impact cancer has on individuals, families and communities.
- [PRESSWIRE] ROME & BALERNA, Switzerland – 15 February, 2016 — The leading Italian pharmaceutical company Angelini has started the promotion and marketing of a new active wound cleanser in Italian hospitals and wound therapy centers.
- [PRESSWIRE] HARLEYSVILLE, Pa. – 02 March, 2016 — Colorcon Inc. announces the opening of a new Technical Service, Laboratory and Conference Facility in Bogotá, Colombia, to support market growth and customers across the Andean countries, Central America and the Caribbean. The new facility is strategically located close to transportation hubs to service the pharmaceutical industry across this region.
- [PRESSWIRE] DUBLÍN y MADRID – 04 March, 2016 — Altan Pharma Limited (“Altan”), empresa farmacéutica irlandesa especializada, ha anunciado hoy que ha lanzado en España la solución Linezolid 2mg/ml para perfusión para el tratamiento de la neumonía extrahospitalaria y la neumonía nosocomial a través de su filial española Genéricos Españoles Laboratorio, S.A.U.
- [PRESSWIRE] DUBLIN – 04 March, 2016 — Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announced that it has signed a licensing agreement to commercialise a generic version of caspofungin. The agreement covers the territories of Germany, France, Italy, Spain, the United Kingdom, Belgium, Portugal, Poland and Latin America.
- [PRESSWIRE] CAMBRIDGE, Mass. – 07 March, 2016 — Today, senior leaders from more than a dozen biopharmaceutical companies came together with world-class academic clinicians from four leading cancer centers, representatives from oncology non-profits, the FDA, and other key stakeholder organizations to advance one of the most promising avenues for curing cancer: accelerating the development of investigational drug combination therapies.
- [PRESSWIRE] CAMBRIDGE, England – 11 April, 2016 — Genestack, the developer of a next generation enterprise platform for genomics research and development, has partnered with the Cancer Molecular Diagnostic Laboratory (CMDL), an organisation involving Cancer Research UK, the University of Cambridge, the Cambridge University Hospitals NHS Trust and the Medical Research Council, to bring advanced genomic technologies into clinical practice.
- [PRESSWIRE] ARDSLEY, N.Y. – 20 May, 2016 — Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will discontinue development of PLUMIAZTM (diazepam) Nasal Spray, an investigational therapy being studied for the treatment of seizure clusters in people with epilepsy.
- [PRESSWIRE] WEST CONSHOHOCKEN, Pa. – 06 July, 2016 — BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam) 1% to thirty days from seven.
- [PRESSWIRE] DUBLIN – 06 July, 2016 — Hibergene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has launched its HG Group B Streptococcus (GBS) Test.
- [PRESSWIRE] STOCKHOLM – 08 July, 2016 — Regulatory News: The interest in and acceptance of SciBase’s method for early detection of malignant melanoma is increasing, which is demonstrated by the fact that the 100th clinic in Germany installed SciBase’s device Nevisense in June. Sales of electrodes; an effect of the adoption of Nevisense, are steadily increasing and rose by 208 percent in Germany during 2015.
- [PRESSWIRE] SAINT PETERSBURG, Russia – 11 July, 2016 — Biotechnological company BIOCAD has developed innovative medicine for treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other autoimmune diseases.
